Sarepta Therapeutics (SRPT) EPS (Basic) (2010 - 2026)
Sarepta Therapeutics' quarterly EPS (Basic) came in at $3.15 in Q1 2026, up 168.48% year-on-year from $1.17 in Q1 2025, and up 180.15% quarter-over-quarter from -$3.93 in Q4 2025.
Sarepta Therapeutics has reported EPS (Basic) for 17 years, with the latest figure at $3.15 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 168.48% year-over-year to $3.15; the trailing twelve-month figure through Mar 2026 stood at $0.73 (up 128.85% YoY), and the FY2025 full-year result was -$7.13, down 388.66% from the prior year.
- EPS (Basic) for Q1 2026 stood at $3.15, up from -$3.93 in the prior quarter.
- The five-year high for EPS (Basic) was $3.15 in Q1 2026, with the low at -$5.86 in Q1 2023.
- Average EPS (Basic) over 5 years is -$0.9, with a median of -$0.46 recorded in 2023.
- Peak annual rise in EPS (Basic) reached 2771.43% in 2025, while the deepest fall reached 1310.53% in 2025.
- Tracing SRPT's EPS (Basic) over 5 years: stood at -$1.24 in 2022, then jumped by 161.29% to $0.76 in 2023, then surged by 117.11% to $1.65 in 2024, then plunged by 338.18% to -$3.93 in 2025, then soared by 180.15% to $3.15 in 2026.
- The last three EPS (Basic) figures came in at $3.15 (Q1 2026), -$3.93 (Q4 2025), and -$0.5 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 3.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.15 |
| Dec 31, 2025 | -3.93 |
| Sep 30, 2025 | -0.50 |
| Jun 30, 2025 | 2.01 |
| Mar 31, 2025 | -4.60 |
| Dec 31, 2024 | 1.65 |
| Sep 30, 2024 | 0.35 |
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.38 |
| Dec 31, 2023 | 0.76 |
| Sep 30, 2023 | -0.46 |
| Jun 30, 2023 | -0.27 |
| Mar 31, 2023 | -5.86 |
| Dec 31, 2022 | -1.24 |
| Sep 30, 2022 | -2.94 |
| Jun 30, 2022 | -2.65 |
| Mar 31, 2022 | -1.20 |
| Dec 31, 2021 | -1.43 |
| Sep 30, 2021 | -0.60 |
| Jun 30, 2021 | -1.02 |
| Mar 31, 2021 | -2.10 |
| Dec 31, 2020 | -2.40 |
| Sep 30, 2020 | -2.50 |
| Jun 30, 2020 | -1.93 |
| Mar 31, 2020 | -0.23 |
| Dec 31, 2019 | -3.16 |
| Sep 30, 2019 | -1.70 |
| Jun 30, 2019 | -3.74 |
| Mar 31, 2019 | -1.07 |
| Dec 31, 2018 | -2.05 |
| Sep 30, 2018 | -1.15 |
| Jun 30, 2018 | -1.67 |
| Mar 31, 2018 | -0.55 |
| Dec 31, 2017 | -0.37 |
| Sep 30, 2017 | -0.78 |
| Jun 30, 2017 | -1.15 |
| Mar 31, 2017 | 1.53 |
| Dec 31, 2016 | -1.62 |
| Sep 30, 2016 | -1.18 |
| Jun 30, 2016 | -1.35 |
| Mar 31, 2016 | -1.31 |
| Dec 31, 2015 | -1.44 |
| Sep 30, 2015 | -1.25 |
| Jun 30, 2015 | -1.01 |
| Mar 31, 2015 | -1.49 |
| Dec 31, 2014 | -1.08 |
| Sep 30, 2014 | -0.71 |
| Jun 30, 2014 | -0.85 |
| Mar 31, 2014 | -0.75 |
| Dec 31, 2013 | -0.23 |
| Sep 30, 2013 | -1.24 |
| Jun 30, 2013 | -0.60 |
| Mar 31, 2013 | -1.32 |
| Dec 31, 2012 | -2.36 |
| Sep 30, 2012 | -2.17 |
| Jun 30, 2012 | 0.36 |
| Mar 31, 2012 | -0.78 |
| Dec 31, 2011 | -0.06 |
| Sep 30, 2011 | -0.18 |
| Jun 30, 2011 | 0.06 |
| Mar 31, 2011 | 0.10 |
| Dec 31, 2010 | -1.52 |
| Sep 30, 2010 | -0.07 |
| Jun 30, 2010 | -0.15 |